🔍 See what insiders are buying — free 7-day trial, no credit card required.
Get started →
HUM
NYSE
🇺🇸 US
Humana Inc.
Healthcare
24Score
DipBuster Score™
$363.82
+$1.66 (+0.46%)
Live price · Source: Yahoo
52-Week Position
$163.11
76% of range
$428.88
Beta
0.717
Low vol
Dividend
—
no income
Mkt Cap
N/A
total value
Mkt CapN/A
P/EN/A
DividendNone
Beta0.717
52W High$428.88
52W Low$163.11
DipBuster Brief
Key signals at a glance
Zone: Consider Trimming
Neutral
Mid-Range Position (76% of 52-Week Range)
The stock sits in the middle of its annual range — no extreme dip opportunity, but also not overextended.
Neutral
Earnings Data Unavailable
P/E ratio could not be determined — this is common for early-stage, loss-making, or recently-listed companies.
Valuation
P/E Ratio—
Mkt CapN/A
52W Position76% of range
EV/EBITDA—
Cash Flow
FCF Yield—
FCF / Share
Op. Cash Flow—
Margins
Gross Margin—
Op. Margin—
Net Margin—
Balance Sheet
Cash—
Total Debt—
Net Cash—
Dividend
Yield—
Annual / shNone
Beta0.717
🔒
FCF, margins & balance sheet data are hidden — create a free account to see them.
🕵️ Insiders
📊 Valuation
💰 Dividends
📰 News
🤖 AI Analysis
Recent director dealings and insider transactions at Humana Inc. (HUM), from SEC Form 4 filings. Open-market buys by directors spending their own money are one of the strongest signals in investing.
| Date | Insider | Type | Shares |
|---|---|---|---|
| 2026-08-01 | Smith Paul John | BUY | 544 |
| 2026-08-01 | Crawford Frederick John | BUY | 544 |
| 2026-06-30 | Hilzinger Kurt J | BUY | 233 |
| 2026-05-01 | Field Robert Stuart | BUY | 852 |
| 2026-05-01 | Martin Aaron | BUY | 8,206 |
| 2026-05-01 | Mehta Japan | BUY | 9,448 |
| 2026-05-01 | Dintenfass David | BUY | 11,273 |
| 2026-05-01 | Rechtin James A. | BUY | 35,633 |
| 2026-05-01 | Shetty Sanjay K | BUY | 9,945 |
| 2026-05-01 | O'hara Michelle A. | BUY | 10,485 |
Valuation
P/E RatioN/A
Market CapN/A
Beta0.717
Dividend/yrNone
52W High$428.88
52W Low$163.11
52-Week Range
$163.11Now$428.88
76% through annual range
From 52W High−15.2%
From 52W Low+123.1%
📖 Plain English Summary
Humana Inc. is at 76% of its 52-week range. Beta 0.717 — tends to move less than the market.
🏦 Analyst Price Target
Loading…
🎯 Analyst Revenue & EPS Estimates
Loading estimates…
🔄 Peer Comparison
Loading peers…
Loading dividend data…
Latest news for HUM
🟢 Bullish
⬜ Neutral
🔴 Bearish
🤖
DipBuster AI Analysis — HUM
Heuristic · balance sheet, insider filings, price data, academic research
Humana Inc. — DipBuster Score 24/100
Graham value assessment, NCAV analysis, price zones...
Insider signals, cluster detection, risk factors...
Track Humana Inc. free
Add HUM to a watchlist, set insider-buy and price alerts, and get the full financial picture — free account, no card.
Sponsored · FCA Regulated Broker
Trading 212
Commission-free investing. ISA and GIA available. FCA regulated.
Free share worth up to £100 when you sign up
Capital at risk. Your investments can go down as well as up. Disclaimer
DipBuster Score™ Breakdown
Value & P/E
0/30
Dip Position
10/25
Momentum & Volume
9/25
Quality & Size
5/10
Insider Activity
0/10
🎯 Dip Buyer Signal
20
/100 · NEUTRAL
dip depth
2/25
oversold rsi
7/25
mean reversion
11/15
insider zone
0/25
capitulation
0/10
Insiders' avg buy price: $185.21 — marked 🟡 on the chart above.
Technical signal only. Not financial advice.
Quick Take
⚪
Not a Dip
DipBuster Score: 24/100
📊
Run a full check in the AI analysis tab for a deeper look.
Company Profile
Humana Inc., a prominent health and well-being enterprise, operates across the United States through its various subsidiary companies. Its operational structure is divided into three main segments: Retail, Group and Spec…
Sector
Healthcare
Market
🇺🇸 US
CEO
James A. Rechtin
Staff
67,060 employees
Website